Christopher M. Smith - 03 Jan 2022 Form 4 Insider Report for Ortho Clinical Diagnostics Holdings plc (OCDX)

Role: Chairman and CEO, Director
Signature: /s/ Michael A. Schlesinger, Attorney-in-Fact
Issuer symbol: OCDX
Transactions as of: 03 Jan 2022
Transactions value $: -$853,800
Form type: 4
Filing time: 05 Jan 2022, 15:23:58
Previous filing: 04 Aug 2021
Next filing: 01 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCDX	Ordinary Shares, $0.00001 par value	Options Exercise	$1.26M	+100K	+27.22%	$12.56	467K	03 Jan 2022	Direct
transaction	OCDX	Ordinary Shares, $0.00001 par value	Sale	-$2.11M	-100K	-21.4%	$21.10	367K	03 Jan 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCDX	Stock Option	Options Exercise	$0	-100K	-9.66%	$0.00	936K	03 Jan 2022	Ordinary Shares, $0.00001 par value	100K	$12.56	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
F3	Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.4000
F4	The stock option vests in three equal annual installments beginning on September 9, 2020.